{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:42:54Z","timestamp":1762332174755,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clon.2024.103740","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T14:08:38Z","timestamp":1734444518000},"page":"103740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands\u2013A Nationwide Overview From 2008 Until 2022"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-9786","authenticated-orcid":false,"given":"J.","family":"Evers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1866-7367","authenticated-orcid":false,"given":"M.J.C.","family":"van der Sangen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-2559","authenticated-orcid":false,"given":"M.C.","family":"van Maaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-8702","authenticated-orcid":false,"given":"J.H.","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-3003","authenticated-orcid":false,"given":"L.","family":"Strobbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.W.M.","family":"Bloemers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.H.J.G.","family":"van den Bongard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Struikmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-824X","authenticated-orcid":false,"given":"S.","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2024.103740_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ","volume":"41","author":"Kerlikowske","year":"2010","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clon.2024.103740_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","article-title":"The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening","volume":"181","author":"van Luijt","year":"2016","journal-title":"Breast Cancer Res"},{"year":"2020","series-title":"National Breast Cancer Guideline [Dutch]","key":"10.1016\/j.clon.2024.103740_bib5"},{"year":"2022","series-title":"Clinical practice guideline in breast cancer","key":"10.1016\/j.clon.2024.103740_bib6"},{"key":"10.1016\/j.clon.2024.103740_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"308","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib8","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"3132","author":"Donker","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41416-021-01496-6","article-title":"Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast","volume":"12510","author":"van Seijen","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2024.103740_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10549-020-06055-w","article-title":"Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands","volume":"1871","author":"Luiten","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2024.103740_bib11","first-page":"162","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"41","author":"Correa","year":"2010","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clon.2024.103740_bib12","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"2421","author":"Bijker","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-023-07168-8","article-title":"The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population","author":"Alaeikhanehshir","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2024.103740_bib14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer Outcomes in DCIS Patients Without Locoregional Treatment","volume":"1119","author":"Ryser","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clon.2024.103740_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejso.2017.12.007","article-title":"Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ","volume":"444","author":"Maxwell","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.breast.2022.01.001","article-title":"Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study","volume":"61","author":"Maxwell","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.clon.2024.103740_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076022","article-title":"Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study","volume":"383","author":"Schmitz","year":"2023","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.clon.2024.103740_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41379-020-00665-x","article-title":"Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy","volume":"34","author":"Schnitt","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clon.2024.103740_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.trecan.2019.05.005","article-title":"Avoiding Overtreatment of Ductal Carcinoma in situ","volume":"57","author":"van der Borden","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clon.2024.103740_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.clon.2024.103740_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.6004\/jnccn.2015.0088","article-title":"Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care","volume":"136","author":"Mukhtar","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clon.2024.103740_bib26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study","volume":"3411","author":"Sagara","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib27","first-page":"1413","article-title":"Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review","author":"Schmitz","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clon.2024.103740_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement","volume":"72","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","author":"Chua","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2024.103740_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2018.11.033","article-title":"Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors","volume":"314","author":"Schreuder","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2024.103740_bib31","unstructured":"WebPathology, Scarff-Bloom-Richardson Histologic Grading. Available from: https:\/\/www.webpathology.com\/image.asp?case=290&n=31#:\u223c:text=A%20numerical%20scoring%20system%20is,%2Ddifferentiated%20(Grade%20III). [cited 2023, June, 26]."},{"key":"10.1016\/j.clon.2024.103740_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cjp2.201","article-title":"Variability in grading of ductal carcinoma in situ among an international group of pathologists","volume":"73","author":"van Seijen","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.clon.2024.103740_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson Comorbidity Index: A Critical Review of Clinimetric Properties","volume":"911","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.clon.2024.103740_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.breast.2013.11.001","article-title":"Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands","volume":"231","author":"van Steenbergen","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.clon.2024.103740_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-022-06831-w","article-title":"Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network","author":"Kim","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2024.103740_bib37","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1245\/s10434-012-2413-4","article-title":"Biology, treatment, and outcome in very young and older women with DCIS","volume":"1912","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib38","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1245\/s10434-022-12361-y","article-title":"Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ","volume":"2913","author":"Tesch","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2024.103740_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-022-06732-y","article-title":"Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study","author":"Eijkelboom","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2024.103740_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-021-01073-7","article-title":"Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study","volume":"141","author":"Eijkelboom","year":"2021","journal-title":"J\u00a0Hematol Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524005442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524005442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:36:38Z","timestamp":1762331798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655524005442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"alternative-id":["S0936655524005442"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.103740","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands\u2013A Nationwide Overview From 2008 Until 2022","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.103740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103740"}}